Clinical Genetics · Orange, CA
NPI
1104395656
Since 2018
Specialty
Clinical Genetics
Code 207SG0201X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1201 W la Veta Ave
Orange, CA, 92868
Phone (714) 509-4873
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
11 prescriptions
Company payments, 2025
$5,886
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Walla Al-Hertani prescribed most often to Medicare patients was Ravicti (Glycerol Phenylbutyrate), with 11 prescriptions and refills. In total Walla Al-Hertani wrote 11 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ravicti Glycerol Phenylbutyrate | 11 | 11 | Under 11 | $1.1M |
Brand drugs: 11 claims; generic drugs: 0 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walla Al-Hertani $5,886 ($5,886 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amicus Therapeutics, Inc. with $2,465.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.